ByTrending Posts
Will the US Health Agency Expand Coverage for…
The U.S. Centers for Medicare & Medicaid Services (CMS) announced a new voluntary program to expand coverage of…
How is Bristol Myers Squibb Driving Growth After…
Bristol Myers Squibb (BMS) continues to build momentum in its post-loss-of-exclusivity strategy, with 2025 marked as a year…
Will Agios Pharma’s FDA Approval Expansion Drive a…
Cambridge, Massachusetts | December 26, 2025 Agios Pharmaceuticals announced a major regulatory milestone after the U.S. Food and…
Novartis Builds on a Track Record of Expansion…
Basel, Switzerland Novartis closed 2025 with sustained operational momentum, building on its transformation into a pure-play innovative medicines…
Regeneron to Present at 44th Annual J.P. Morgan…
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including…
Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical Association (JAMA) Neurology…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer…
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…
Is Samsung Biologics Set to Expand U.S. Operations…
Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug production facility from…
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription…
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…
Trending Posts
Latest Stories
Could Amgen’s 340B Pricing Practices Face Legal and Market Scrutiny?
23 January 2026 Executive Summary A healthcare advocacy group, Sagebrush, has filed a lawsuit against…
Is Novo Nordisk Positioning Cell-Based Therapies as the Future of Diabetes Care?
23 January 2026 Executive Summary Novo Nordisk has expanded its strategic collaboration with Canadian biotech…
Is Novo Nordisk Facing Legal Scrutiny Over Diabetes Drug Market Conduct?
23 January 2026 Executive Summary Novo Nordisk is facing a new class-action lawsuit in the…
Is Novo Nordisk’s Oral Wegovy Off to a Record Start? Early Prescription Surge Signals Strong Momentum
23 January 2026 Executive Summary Novo Nordisk’s newly launched oral Wegovy weight-loss therapy has recorded…
Gallery
